NaviGate touts “excellent” valvular function at 1 year with Gate tricuspid valve

May 21, 2018 By Fink Densford Leave a Comment

NaviGate Cardiac Structures Inc today touted that the first patient to receive its Gate tricuspid valved stent through a transjugular access procedure under compassionate use protocols has reached one year post-procedure and still maintains excellent valvular function.

The procedure was performed last April at the Cleveland Clinic, the Lake Forest, Calif.-based company said. At one year, the patients’ bioprosthesis is demonstrating “excellent leaflet mobility and valve function,” NaviGate said.

A total of 16 patients have been treated with the valve for severe tricuspid regurgitation, the company said, with most patients being treated at the Columbia Presbyterian Hospital. A total of four patients have been treated with the Gate valve at the Cleveland Clinic with no reported 30-day mortality.

“NCSI is working diligently to move into a feasibility clinical trial to initiate Safety and Effectiveness research of the tricuspid bioprosthesis. These compassionate plea patient implants are instructive and obviously are good for the patients who have no other recourse, although we find several who cannot be helped by the valve since their ventricular function is beyond repair and their postoperative course would be troubled. Careful patient selection is imperative to obtain proof of what the GATETM tricuspid valved stent bioprosthesis can or cannot do, and that requires a well-controlled clinical trial to obtain such evidence, which we hope to start later in the year. Until then, we have requests from many centers in Europe, the U.S. and Canada to do both: more compassionate cases and a full trial,” NCSI CEO Dr. R. Quijano said in a press release.

In February, NaviGate said that its catheter-guided Gate valved-stent bioprosthesis became the first orthotopic valve replacement in Canada to treat severe tricuspid regurgitation.

Johnson & Johnson hits the Big Apple with latest JLabs site
Johnson & Johnson (NYSE:JNJ) opened its latest life science incubator in New York City, the healthcare giant said today. The 30,000-square-foot JLabs @ NYC is a collaboration between Johnson & Johnson Innovation, New York State and the New York Genome Center. Sited at the genome center in SoHo, the incubator is home to 26 startups and […]
Medtech venture investing trends: Here’s what you need to know
Ask any early-stage medtech or digital health entrepreneur, and they’ll tell you how tough it is. There’s tremendous competition for venture investing, coupled with a pullback by previously traditional investors in this space. Bill Evans While venture investment in medtech and digital health has recovered since the financial crisis of a decade ago — setting […]
This wireless system powers devices inside the body
Massachusetts Institute of Technology researchers and Brigham and Women’s Hospital scientists have developed a wireless, ingestible system that can power and communicate with devices that are implanted deep within the body. The researchers suggest that the system could be used to deliver drugs, monitor conditions inside the body or treat diseases by stimulating the brain […]
Resonetics acquires Swiss manufacturer Medelec
Resonetics (Nashua, N.H.) announced today that it has acquired Medelec (Puidoux, Switzerland). The financial details of the deal were not disclosed. “We are excited about the Medelec team joining Resonetics. Marc and Sandra But have established a very strong reputation in the medtech industry for precision and quality and have made significant investments in technology […]
Data Sciences International launches inhalation exposure system
Data Sciences International, a subsidiary of Harvard Bioscience, recently launched a new inhalation and exposure system called the DSI Buxco Inhalation Exposure System. The new inhalation exposure system is designed for ease-of-use for researchers while also giving them flexibility. It features remote sensors and hardware control system that are linked by a microprocessor-based feedback loop. […]
Medical devices: When should you make them smarter?
The drive toward value in healthcare has increased demand for smarter medical devices able to provide information for real-time feedback, as well as after-the-fact analysis. So when does it make sense to actually make a medical device smarter? And how do you go about it? Tom KraMer, CEO of Kablooe Design outside Minneapolis, has a […]
Bluebee receives ISO 13485 certification
Bluebee recently announced that it has received ISO 13485 medical device quality standard certification for its design and development of software solutions and data processing algorithms intended for use in diagnostics and clinical reporting. The certification body BSI certified that Bluebee’s design, development, installation, testing and servicing of custom-made software solutions and data processing algorithms […]
No-shows at radiology can cost a hospital $1 million a year, study says
People who fail to show up for radiology appointments cost hospitals about $1 million per year on average, according to a new study. That’s as much as the cost of a new 3T MR scanner. Most of the no-shows at academic medical centers were for mammography appointments, according to the study, published in Current Problems […]
Hey, Google! When will I die?
Google’s AI capabilities can predict with greater accuracy than a hospital’s computers when a critically ill patient will die, according to a new study. Using a patient’s entire chart, Google’s deep learning methods were able to predict, 24 hours after admission, the risk of that patient’s death at 19.9% while the regular hospital’s computers predicted […]
Johnson & Johnson launches new self-shortening Dynacord suture
Johnson & Johnson through its DePuy Synthes franchise has announced the U.S. launch of its Dynacord suture for soft tissue repair in areas such as the rotator cuff in the shoulder. The Dynacord suture, available on Healix Advance anchors, is part of the DePuy Synthes Mitek Sports Medicine portfolio. J&J launched Dynacord today at the San […]
Stocks slide further as Trump doubles down on China tariffs
The Trump administration yesterday added $200 billion worth of tariffs to the $50 billion in trade levies already slated to go into place next month and threatened to add $200 billion more, sending share prices down. The news put the Dow Jone Industrial Average on track for its longest losing streak in 15 months and […]